Source link : https://newshealth.biz/health-news/folfirinox-vs-crt-in-pancreatic-cancer-is-one-better/
Neoadjuvant FOLFIRINOX and gemcitabine-based chemoradiotherapy yield similar overall survival in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma. Medscape Medical News Source link : https://www.medscape.com/viewarticle/folfirinox-vs-crt-pancreatic-cancer-one-better-2025a1000p19?src=rss Author : Publish date : 2025-09-19 17:55:00 Copyright for syndicated content belongs to the linked Source.
The post FOLFIRINOX vs CRT in Pancreatic Cancer: Is One Better? first appeared on News Health.
—-
Author : News Health
Publish date : 2025-09-19 17:55:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8